Standard Capital Markets Ltd
BSE:511700
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Infant Bacterial Therapeutics AB
STO:IBT B
|
SE |
|
A
|
AstraZeneca PLC
LSE:0A4J
|
UK |
|
FibroGen Inc
NASDAQ:FGEN
|
US |
Standard Capital Markets Ltd
Other
Standard Capital Markets Ltd
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Standard Capital Markets Ltd
BSE:511700
|
Other
₹1.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Muthoot Finance Ltd
NSE:MUTHOOTFIN
|
Other
₹867.7m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Bajaj Finance Ltd
NSE:BAJFINANCE
|
Other
₹26.5B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Cholamandalam Investment and Finance Company Ltd
NSE:CHOLAFIN
|
Other
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Shriram Finance Ltd
NSE:SHRIRAMFIN
|
Other
₹135.8B
|
CAGR 3-Years
58%
|
CAGR 5-Years
57%
|
CAGR 10-Years
N/A
|
|
|
Tata Capital Ltd
NSE:TATACAP
|
Other
-₹3.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Standard Capital Markets Ltd
Glance View
Standard Capital Markets Ltd. engages in the business of non banking financial activities. The company is headquartered in New Delhi, Delhi. The firm is engaged in providing value added services and products to its loan customers.
See Also
What is Standard Capital Markets Ltd's Other?
Other
1.4B
INR
Based on the financial report for Mar 31, 2025, Standard Capital Markets Ltd's Other amounts to 1.4B INR.